Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting

Abstract

BackgroundAmyloidoses are characterized by the extracellular deposition of insoluble fibrillar proteinaceous aggregates highly organized into cross-β structure and referred to as amyloid fibrils. Nowadays, the diagnosis of these diseases remains tedious and involves multiple examinations while an early and accurate protein typing is crucial for the patients’ treatment. Routinely used neuroimaging techniques such as magnetic resonance imaging (MRI) and positron emission tomography (PET) using Pittsburgh compound B, [11C]PIB, provide structural information and allow to assess the amyloid burden, respectively, but cannot discriminate between different amyloid deposits. Therefore, the availability of efficient multimodal imaging nanoparticles targeting specific amyloid fibrils would provide a minimally-invasive imaging tool useful for amyloidoses typing and early diagnosis. In the present study, we have functionalized gadolinium-based MRI nanoparticles (AGuIX) with peptides highly specific for Aβ amyloid fibrils, LPFFD and KLVFF. The capacity of such nanoparticles grafted with peptide to discriminate among different amyloid proteins, was tested with Aβ(1–42) fibrils and with mutated-(V30M) transthyretin (TTR) fibrils.ResultsThe results of surface plasmon resonance studies showed that both functionalized nanoparticles interact with Aβ(1–42) fibrils with equilibrium dissociation constant (Kd) values of 403 and 350 µM respectively, whilst they did not interact with V30M-TTR fibrils. Similar experiments, performed with PIB, displayed an interaction both with Aβ(1–42) fibrils and V30M-TTR fibrils, with Kd values of 6 and 10 µM respectively, confirming this agent as a general amyloid fibril marker. Thereafter, the ability of functionalized nanoparticle to target and bind selectively Aβ aggregates was further investigated by immunohistochemistry on AD like-neuropathology brain tissue. Pictures clearly indicated that KLVFF-grafted or LPFFD-grafted to AGuIX nanoparticle recognized and bound the Aβ amyloid plaque localized in the mouse hippocampus.ConclusionThese results constitute a first step for considering these functionalized nanoparticles as a valuable multimodal imaging tool to selectively discriminate and diagnose amyloidoses.Electronic supplementary materialThe online version of this article (doi:10.1186/s12951-016-0212-y) contains supplementary material, which is available to authorized users.

Lanthanide conjugates as versatile instruments for therapy and diagnostics

“…69 Conjugation of specific peptides and other small biomolecules to nanocomposites has been extensively studied. [70][71][72][73][74] The cytokine interleukin-13 was chosen as a reliable sensor for glioblastoma multiforme cells in xenografted mice. Lanthanide-doped metallofullerene-based interleukin-13 nanoparticles paved the way for specific theranostic treatment of this common malignant brain tumour which is characterized by a median survival rate of merely one year.…”

Multimodal AGuIX® Nanoparticles: Size Characterization by HF5 and Optimization of the Radiolabeling with Various SPECT/PET/Theranostic Tracers

“…For instance, targeting molecules such as cRGD, ATWLPPR have been proposed to target malignant cells or neovesssels [10,11]. Peptides highly specific for Aβ amyloid fibrils in the case of Alzheimer disease have also been proposed [12]. The carboxylic acid groups of DOTA on GBN surface can also bind aromatic quaternary ammonium (QA) functions and increase the accumulation in the tumor site in the case of chondrosarcoma.…”

Potential therapeutics of Alzheimer's diseases: New insights into the neuroprotective role of trehalose‐conjugated beta sheet breaker peptides

“…A variety of small peptides that inhibit aggregation of Aβ and reduce its toxic effects have been already described and some of them showed to be effective in AD rodent animal models . Moreover, Aβ binding peptides have been proposed for suitable uses in in vivo imaging and early diagnosis of AD …”